NGL Fine-Chem Limited (NSE:NGLFINE)
2,928.00
+97.60 (3.45%)
Sep 24, 2026, 11:55 AM IST
NGL Fine-Chem Market Cap
NGL Fine-Chem has a market cap or net worth of 17.59 billion as of September 23, 2026. Its market cap has increased by 102.33% in one year.
Market Cap
17.59B
Enterprise Value
18.37B
Revenue
5.36B
Ranking
n/a
PE Ratio
30.70
Stock Price
2,928.00
ChartMarket Cap Chart
Since December 24, 2004, NGL Fine-Chem's market cap has increased from 80.40M to 17.59B, an increase of 21,773.59%. That is a compound annual growth rate of 28.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 17.59B | 102.03% |
| Dec 31, 2025 | 8.70B | -21.72% |
| Dec 31, 2024 | 11.12B | -19.33% |
| Dec 29, 2023 | 13.79B | 44.38% |
| Dec 30, 2022 | 9.55B | -42.81% |
| Dec 31, 2021 | 16.70B | 140.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Rubicon Research | 286.80B |
| Pfizer | 184.62B |
| Marksans Pharma | 153.21B |
| CORONA Remedies | 134.66B |
| Sanofi Consumer Healthcare India | 92.07B |
| Senores Pharmaceuticals | 64.25B |
| SMS Pharmaceuticals | 43.69B |
| Sai Parenteral's | 22.57B |